You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (2) |
Back to Search
Combining Lipophilic Prodrugs and Nanomedicines to Facilitate Oral Chemotherapy
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-105-Tuesday
- By: PRESTIDGE, Clive (University of South Australia, School of Pharmacy & Medical Sciences, Adelaide, Australia)
- Co-author(s): Clive Prestidge: School Pharmacy, UniSA, Adelaide, Australia
Vaskor Bala: School Pharmacy, UniSA, Adelaide, Australia
Shasha Rao: School Pharmacy, UniSA, Adelaide, Australia - Abstract:
Backgrounds
Irinotecan is a water soluble prodrug of SN38 (7-ethyl-10-hydroxy camptothecin) used in advance colorectal cancer therapy and dosed by intravenous infusion. Its application is dose limited due to gastro-intestinal toxicity. Furthermore, a number of pharmaceutical and pharmacological challenges conspire to limit the oral absorption of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026